JMCR Partners
Overview
JMCR Partners is a venture capital firm established in 2013, focusing on managing private assets for its founding family. The firm primarily invests in the biotechnology and healthcare sectors, aiming to leverage growth opportunities within these critical industries. Operating alongside two other asset management companies, JMCR Capital and JMRE, JMCR Partners specializes in private equity and quantitative investment strategies. The firm has made 23 investments, with its most recent investment in Clues Therapeutics Inc. on July 20, 2020. With offices in Shanghai, Boston, and London, JMCR Partners seeks to identify and support innovative companies in the biotechnology and healthcare sectors, contributing to advancements in pharmaceuticals, therapeutics, and clinical trials.
Investment Focus
- Innovative biotechnology and healthcare companies
- Strong growth potential
- Experienced management teams
Portfolio Companies
Reach JMCR Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about JMCR Partners
What sectors does JMCR Partners invest in?
JMCR Partners invests in Healthcare, Pharmaceuticals, Biotechnology, Clinical Trials and Therapeutics, and is based in China. JMCR Partners is listed as a family office in the ConnectSafely investor database.
What stage does JMCR Partners invest at?
JMCR Partners backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage.
Which regions does JMCR Partners invest in?
JMCR Partners invests across United States, United Kingdom and China.
What companies has JMCR Partners invested in?
JMCR Partners's portfolio includes Clues Therapeutics Inc..
Last updated · Source: ConnectSafely investor database
